Improve-it trial summary

WitrynaIn order to improve compliance on the posting of results, the primary aim of this communication is to remind all sponsors about their obligation for the reporting of clinical trial summaries in the EU Clinical Trials Database. In the spirit of the EU legislation, it is important that all stakeholders act Witryna12 kwi 2015 · The IMPROVE-IT trial, launched 9 years ago, has finally provided physicians with long-term efficacy and safety evidence for ezetimibe. The large-scale …

Digital adherence technologies to improve tuberculosis treatment ...

Witryna17 lis 2014 · A. Adding ezetimibe, a non-statin agent, to statin therapy reduces cardiovascular events in high-risk patients with acute coronary syndrome (ACS), according to results of the IMPROVE-IT Trial presented Nov. 17 at AHA 2014. The study was led by Christopher P. Cannon, MD, FACC, professor of medicine at Harvard … WitrynaFindings In a prespecified analysis of 15 281 patients enrolled in IMPROVE-IT, patients achieving an LDL-C level of less than 30 mg/dL at 1 month after acute coronary … norris jaclyn cosmetics https://qandatraders.com

IMPROVE-IT TRIAL - CardiologyTrials.org

Witrynaplacebo‐controlled trial design, the benefit could have been due to the statin alone. SHARP What IMPROVE‐IT may add? Ezetimibe may modestly lower CV event risk … Witryna1 cze 2024 · PINNACLE Cohort and IMPROVE-IT Trial Patient Characteristics View LargeDownload 1. Cannon CP, Blazing MA, Giugliano RP, Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med. 2015;372(25):2387-2397. PubMedGoogle ScholarCrossref 2. Maddox TM, Masoudi FA, Oetgen Witryna2 lis 2024 · IMPROVE-IT was a multinational, double-blind, randomised, placebo-controlled trial that enrolled 18 144 patients who had been stabilised after an acute coronary syndrome. Recruitment was from Oct 26, 2005, to July 8, 2010, and the trial reported its primary outcome in June, 2015. The trial was done in 1158 sites in 39 … how to remove yourself from viber group

Ezetimibe Added to Statin Therapy after Acute Coronary …

Category:The new england journal medicine

Tags:Improve-it trial summary

Improve-it trial summary

IMPROVE Intervention Trial Implementing Non-invasive …

WitrynaExpert opinion: The results from IMPROVE-IT revalidated the concept that low-density lipoprotein cholesterol (LDL-C) levels are a clinically relevant treatment goal. This trial … WitrynaVytorin Efficacy International Trial (IMPROVE-IT) evaluated the effect of ezetimibe combined with simvastatin, as compared with that of simva-statin alone, in stable …

Improve-it trial summary

Did you know?

Witryna18 cze 2015 · Video Summary of. Treatment with statins reduces LDL cholesterol and lowers the risk of cardiovascular events. Would the addition of ezetimibe further … WitrynaGoals IMPROVE-IT: First large trial evaluating clinical efficacy of combination EZ/Simva vs. simvastatin (i.e., the addition of ezetimibe to statin therapy): Does lowering LDL-C …

Witryna[The IMPROVE-IT trial] [The IMPROVE-IT trial] [The IMPROVE-IT trial] G Ital Cardiol (Rome). 2015 Dec;16(12):667-71. doi: 10.1714/2088.22578. [Article in Italian] Authors … WitrynaTrial Summary: Opioid vs NonopioidSingle Dose Medications for Acute Extremity Pain in the Emergency Department (ED) May 2024 Opioid Tapering Q&A Patient Booklet Apr 2024 Non-Live Recombinant Herpes Zoster Vaccine (SHINGRIX) 2024 Nov 2024 Exercise Rx(pdf) Nov 2024 Exercise Rx(Word) Nov 2024

Witryna1 maj 2016 · Recent findings: IMPROVE-IT is the first trial that demonstrates a significant clinical benefit of a nonstatin hypolipidemic agent (ezetimibe) used in combination with statin (simvastatin)... WitrynaThe Trial Summary (TS) domain is a trial-level dataset that allows for the submission of a high-level view of a study in a structured format. Each record contains the value of a parameter or characteristic of the trial. It is used to record basic information about the study such as trial phase, protocol title, and trial objectives.

WitrynaRecent findings: IMPROVE-IT is the first trial that demonstrates a significant clinical benefit of a nonstatin hypolipidemic agent (ezetimibe) used in combination with statin …

Witryna5 godz. temu · This article summaries discussions involving academia, the pharmaceutical industry, patient groups, and government agencies held during a 2024 US Food and Drug Administration (FDA) workshop to improve the regulatory and clinical trial infrastructure necessary to develop antifungals for invasive fungal infections. … how to remove your snapchat accountWitryna19 lis 2014 · Con IMPROVE IT finalmente ha aparecido el estudio clínicamente relevante sobre la reducción de los niveles de colesterol con ezetimibe añadido a una estatina (simvastatina, estatina de moderada intensidad según las guías mencionadas), en el que se ha demostrado una mejoría pronóstica a pesar de partir con unos niveles LDL … how to remove your sim card iphoneWitrynaOther trials have shown that digital adherence technologies (SMS-based and those based on medication event reminder monitors), implemented in real-time, can … how to remove your windows passwordWitryna19 lis 2014 · IMPROVE IT posiblemente inducirá algún cambio en las guías en futuras revisiones. Otra posibilidad es que pueda ayudar a evitar la posibilidad de … how to remove your sliding glass doorWitryna18 gru 2014 · The IMPROVE-IT trial provides the first evidence from a large-scale event-driven randomized clinical trial that additional lipid modifying therapy further lowering LDL-C provides further CVD event reduction beyond statin … norris insurance bunker hill indianaWitrynaIMPROVE-IT TRIAL; Problem: Recent acute coronary syndrome with raised LDL: Format: Double-blind RCT: Treatment: Ezetimibe 10mg + Simvastatin 40mg: Control: … how to remove youtube accountWitrynaIMPROVE-IT(Improved Reduction of Outcomes: Vytorin Efficacy International Trial [进一步降低终点事件:葆至能疗效国际试验])是一项在 急性冠脉综合征 的高危患者中 … how to remove your tooth